Mecasermin

Mecasermin

Main Classes of Drugs

Published in Jerome Z. Litt, Neil H. Shear, Litt's Drug Eruption & Reaction Manual, 2017

HormoneEstradiolLevonorgestrelOral ContraceptivesSincalidepolypeptideGlucagonInsulinInsulin AspartMecaserminNesiritideSecretin

Drug treatments and interactions, disease progression and quality of life in ALS patients

View Article

Journal Information

Published in Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 2022

Luca Diamanti, Elisa Bianchi, Klodjana Mucaj, Cristina Cereda, Silvio Garattini, Ettore Beghi, Elisabetta Pupillo

According to the European Federation of Neurological Societies (EFNS) (5), there is insufficient evidence to recommend treatment with vitamins, testosterone, antioxidants such as co-enzyme Q-10 and gingko biloba, intravenous immunoglobulin therapy, cyclosporin, interferons, copaxone, KDI tripeptide, neurotrophic factors (including brain-derived neurotrophic factor (BDNF), insulin-like growth factor 1 (IGF-1) and mecasermin rinfabate), ceftriaxone, creatine, gabapentin, minocycline, stem cells or lithium. As symptomatic treatment aims to improve health-related quality of life (HRQoL) of patients and caregivers, symptoms should be treated as they become prominent and incapacitating (5).

Explore chapters and articles related to this topic

Main Classes of Drugs

Drug treatments and interactions, disease progression and quality of life in ALS patients